Tyrosinemia type I definition

Tyrosinemia type I means a congenital disorder characterized by an accumulation of the amino acid tyrosine due to defective fumarylacetoacetate hydrolase activity.
Tyrosinemia type I means a congenital disorder charac- terized by an accumulation of the amino acid tyrosine due to defective fumarylacetoacetate hydrolase activity.

Examples of Tyrosinemia type I in a sentence

  • Tyrosinemia type I mice display hy- permyelination of the cerebral cortex as well as be- havioral and cognitive impairments in testing com- pared to WT-NTBC and WT-water mice.

  • Succinylacetone is a vital marker of Tyrosinemia type I, which makes the identification of this compound substantial.

  • In terms of annual costs per patient, stands out the decrease in Nitisinone (Tyrosinemia type I) (- 464 MM per patient).

  • In humans mutations in the HPD gene can cause two distinct genetic diseases, Hereditary Tyrosinemia type III (HT III) and Hawkinsinuria, and HPD activity is markedly reduced in the liver of patients with Hereditary Tyrosinemia type I (HT I) [7].

Related to Tyrosinemia type I

  • thalassemia means a group of inherited disorders characterised by reduced or absent amounts of haemoglobin.

  • Embryo/fetus means the developing human organism from conception until the time of birth.

  • Prosthesis means an artificial substitute for a missing body part.

  • Embryo or "fetus" means the developing human organism from conception until time of birth.

  • Total tetrahydrocannabinol means the same as that term is defined in § 3.2-4112.

  • Opioid antagonist means a drug that binds to opioid

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.

  • muscular dystrophy means a group of hereditary genetic muscle disease that weakens the muscles that move the human body and persons with multiple dystrophy have incorrect and missing information in their genes, which prevents them from making the proteins they need for healthy muscles. It is characterised by progressive skeletal muscle weakness, defects in muscle proteins, and the death of muscle cells and tissue;

  • Nursing home-type patients means a patient who has been in hospital more than 35 days, no longer requires acute hospital care, cannot live independently at home or be looked after at home, and either cannot be placed in a nursing home or a nursing home place is not available.

  • Opioid means a drug that produces an agonist effect on opioid receptors and is indicated or used for the treatment of pain.

  • Cannabinoid means any of the chemical compounds that are the active constituents of marijuana.

  • Polystyrene foam means blown polystyrene and expanded and

  • coronavirus means severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2);

  • Cannabinoid edible means food or potable liquid into which a cannabinoid concentrate, cannabinoid extract or dried marijuana leaves or flowers have been incorporated.

  • Diatomaceous earth filtration means a process resulting in substantial particulate removal in which (1) a precoat cake of diatomaceous earth filter media is deposited on a support membrane (septum), and (2) while the water is filtered by passing through the cake on the septum, additional filter media known as body feed is continuously added to the feed water to maintain the permeability of the filter cake.

  • Cannabinoid extract means a substance obtained by separating cannabinoids from marijuana by:

  • haemophilia means an inheritable disease, usually affecting only male but transmitted by women to their male children, characterised by loss or impairment of the normal clotting ability of blood so that a minor would may result in fatal bleeding;

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • Genetic resources means genetic material of actual or potential value;

  • Snow tyre means a tyre whose tread pattern, tread compound or structure is primarily designed to achieve in snow conditions a performance better than that of a normal tyre with regard to its ability to initiate or maintain vehicle motion;

  • Conventional filtration treatment means a series of processes including coagulation, flocculation, sedimentation, and filtration resulting in substantial particulate removal.

  • Embryo/fetus means the developing human organism from conception until the time of birth.

  • Opioid treatment program means a detoxification or maintenance treatment program which is required to report patient identifying information to the central registry and which is located in the state.

  • Physiotherapist means a health care professional who is registered in the part of the register maintained by the Health Professions Council under article 5 of the Health and Social Work Professions Order 2001 (establishment and maintenance of register) relating to physiotherapists and:

  • Acute toxicity means concurrent and delayed adverse effects that result from an acute exposure and occur within any short observation period, which begins when the exposure begins, may extend beyond the exposure period, and usually does not constitute a substantial portion of the life span of the organism.

  • Anaerobic digester means a liquid manure storage area that is constructed with the intent to capture and combust gas emissions resulting from the digestion of waste by microbes in anaerobic conditions. An anaerobic digester is a LMSA and is required to comply with all requirements applicable to LMSAs. Requirements specific to anaerobic digesters will be noted when applicable.